'Healthy enough to contest': Malegaon terror victim's father urge NIA to bar Sadhvi

Agencies
April 18, 2019

Mumbai, Apr 18: An application has been filed before the NIA court here against Malegaon blast accused Sadhvi Pragya Thakur, seeking a bar on her contesting the Lok Sabha poll.

The BJP has declared her candidature from Bhopal seat in Madhya Pradesh.

The applicant has questioned Thakur’s candidature citing that she had got bail on the ground of her poor health, but she is “healthy enough to fight elections.”

“That intervener would further submit that Sadhvi Pragya Thakur got bail on health ground but clearly healthy enough to fight elections in the crippling summer heat which means she has misguided the court,” says applicant Sayyed Bilal in his petition, filed in the NIA court on Thursday.

NIA will file its reply on April 23 when the court is also likely to hear the petition.

Nisar Ahmed Sayyed Bilal lost his son Sayyed Azhar Nisar Ahmed on the spot in Malegaon blast that took place on September 29, 2008.

The applicant states that “he came to know by electronic, print and social media that Sadhvi Pragya Thakur has joined the BJP and is going to contest parliamentary elections from Bhopal seat.”

The petitioner has submitted that Thakur was “enlarged on conditional bail and she is not attending hearing of this court on the pretext that she is unwell and she is a ‘breast cancer patient.’ But on the contrary, she has been seen participating in various programmes and giving objectionable and instigating speeches since her release from the jail.”

Thakur has “flayed her duty to the court under false pretense but has submitted herself to the duty of being a parliamentarian. Sadhvi Pragya Thakur has taken a casual outlook to the trial and it casts serious doubt on her non-availability for the trial and the reasons so told.”

The petitioner has further submitted that “during bail hearing in the Bombay High Court Sadhvi Pragya Thakur had filed written statement in support of her health and claimed that she cannot even walk without support, her contention and the High Court’s observations are being reproduced here for kind perusal of this court.”

“Sadhvi Pragya Thakur got bail on health ground but is clearly healthy enough to fight elections in the crippling summer heat which means she has misguided the court,” applicant Sayyed Bilal said in the application.

“Sadhvi Pragya Thakur may be asked to attend court proceeding here in Mumbai and is barred to contest the election as trial is still in progress and the petition of cancellation of bail is sub-judice before the Supreme Court,” the application added.

Thakur is among seven accused facing trial in Malegaon blast case, in which six people were killed and a dozen others were injured when a bomb placed on a motorcycle exploded in Maharashtra’s Malegaon on September 29, 2008.

Polling in Madhya Pradesh will be held in the last four phases of elections, ending on May 19. The counting of votes will take place on May 23.

Comments

MR
 - 
Friday, 19 Apr 2019

Cancer may be another cooked up lies by Sadvi Pradvi thakur and her BJP lawyer

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 27,2020

New Delhi, Jun 27: Prime Minister Narendra Modi on Saturday said that India fared much better compared to some other countries in the fight against the COVID-19 pandemic. The PM made this observation while delivering the inaugural address to mark the 90th birth anniversary celebrations of Reverend Dr Joseph Mar Thoma Metropolitan.

"Earlier this year, some people had predicted that the impact of the virus in India would be very severe. Due to lockdown, many initiatives have been taken by the Government and in this people-driven fight, India is much better placed than many other nations. India's recovery rate is rising," Modi said in his virtual address.

He further warned that the time was not apt to "let our guard down".

The prime minister greeted the Mar Thoma Metropolitan and wished him a "long life and best health."

"Dr Joseph Mar Thoma has devoted his life for the betterment of our society and nation. He has been particularly passionate about the removal of poverty and women empowerment," the prime minister said.

Praising the Mar Thoma Church for its contributions to the country the Prime Minister added that it has worked to bring a positive difference in the lives of people in the country in areas of healthcare and education.

"The Mar Thoma Church is closely linked with the noble ideals of Saint Thomas, the Apostle of Lord Christ. India has always been open to spiritual influences from many sources. It is with this spirit of humility that the Mar Thoma Church has worked to bring a positive difference in the lives of our fellow Indians," Modi said.

Followers of the Mar Thoma Church from India and abroad participated in the programme through video conference.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 10,2020

New Delhi, Jul 10: With the highest single-day spike of 26,506 COVID-19 cases and 475 deaths reported in the last 24 hours, the total number of COVID-19 cases in India reached 7,93,802 on Friday, according to the Union Ministry of Health and Family Welfare.

Out of the total number of cases, 2,76,685 are active, 4,95,513 have been cured/discharged/migrated and 21,604 have died so far due to the infection.

With as many as 2,30,599 COVID-19 cases, Maharashtra continues to remain the worst-affected state, followed by Tamil Nadu (1,26,581) and Delhi (1,07,051).

Meanwhile, 2,83,659 samples were tested for coronavirus on Thursday, taking the total number of samples tested up to July 9 to 1,10,24,491, according to the Indian Council of Medical Research (ICMR).

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.